Abbott beats quarterly profit, but pulls forecast on coronavirus concerns [Reuters (UK)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Abbott posts 16% fall in profit, suspends 2020 forecast on coronavirus concerns - Reuters 1 Min Read (Reuters) - Abbott Laboratories Inc ( ABT.N ) posted a 16% drop in quarterly profit on Thursday partly due to a tax expense and suspended its full-year forecast citing the uncertainty caused by the coronavirus outbreak. The company’s net earnings fell to $564 million, or 31 cents per share, in the first quarter ended March 31, from $672 million, or 38 cents per share, a year earlier. Net sales rose to $7.73 billion from $7.54 billion. Abbott has so far launched three coronavirus tests in the U.S., including an on-site diagnostic kit that can deliver results within minutes and heralded as a game changer by President Donald Trump. Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Sriraj Kalluvila All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2020 Reuters. All Rights Reserved.
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Evercore ISI to $136.00. They now have a "buy" rating on the stock.MarketBeat
- Abbott Hosts Conference Call for Fourth-Quarter EarningsPR Newswire
- Argentina Diabetes Devices Market to Worth Over US$ 1,031.89 Million by 2033 | Astute Analytica [Yahoo! Finance]Yahoo! Finance
- A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- ABT's page on the SEC website